Concord Medical Services Holdings Limited (CCM) Financial Ratios
17 years of historical data (2008–2024) · Healthcare · Medical - Care Facilities
EV/EBITDA
N/A
—
5yr avg: N/A
30Y Low0.3·High6.9
P/FCF
N/A
—
5yr avg: N/A
30Y Low0.0·High6.5
P/B Ratio
↓
0.00
↑+192% vs avg
5yr avg: 0.00
30Y Low0.0·High0.1
ROE
↓
-18.3%
-15% vs avg
5yr avg: -15.9%
30Y Low-25%·High14%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low0.7·High10.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CCM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Concord Medical Services Holdings Limited currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $748461 | $783328 | $2M | $2M | $3M | $4M | $4M | $5M | $5M | $7M | $7M |
| Enterprise Value | $547M | $3.7B | $3.2B | $3.1B | $2.6B | $2.0B | $1.5B | $539M | $1.1B | $1.0B | $1.0B |
| P/E Ratio → | -0.02 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 |
| P/B Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | 0.18 | — | — |
P/E links to full P/E history page with 30-year chart
CCM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.68 | 6.03 | 6.53 | 5.31 | 9.07 | 7.33 | 2.82 | 3.47 | 2.21 | 1.69 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | 6.88 |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | 59.95 |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
CCM Profitability
Margins and return-on-capital ratios measuring operating efficiency
Concord Medical Services Holdings Limited earns an operating margin of -138.6%. Operating margins have compressed from -111.2% to -138.6% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -18.3% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -20.6% | -20.6% | -14.3% | -32.3% | -11.7% | 5.9% | -8.0% | 10.4% | 29.6% | 37.0% | 42.7% |
| Operating Margin | -138.6% | -138.6% | -86.2% | -111.2% | -94.4% | -141.7% | -220.5% | -156.8% | -64.0% | -37.1% | -0.9% |
| Net Profit Margin | -80.3% | -80.3% | -55.4% | -103.7% | -55.9% | -139.0% | -154.8% | -123.0% | -85.9% | -57.5% | -12.7% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -18.3% | -18.3% | -15.8% | -20.6% | -10.6% | -14.5% | -14.8% | -14.3% | -25.3% | -19.6% | -4.8% |
| ROA | -4.8% | -4.8% | -4.9% | -8.0% | -4.7% | -6.4% | -6.9% | -5.8% | -8.5% | -7.7% | -2.4% |
| ROIC | -7.7% | -7.7% | -6.9% | -7.6% | -7.1% | -6.1% | -10.7% | -9.0% | -7.2% | -5.4% | -0.2% |
| ROCE | -12.2% | -12.2% | -10.3% | -10.2% | -8.9% | -7.4% | -11.8% | -9.9% | -9.1% | -7.4% | -0.3% |
CCM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $3.7B ($3.9B total debt minus $216M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.43 | 2.43 | 1.89 | 1.61 | 1.00 | 0.98 | 0.81 | 0.41 | 1.22 | 0.97 | 1.06 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 10.03 |
| Net Debt / Equity | — | 2.30 | 1.85 | 1.53 | 0.94 | 0.84 | 0.77 | 0.23 | 1.13 | 0.81 | 0.72 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 6.83 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -2.47 | -2.47 | -2.79 | -4.36 | -6.21 | -3.78 | -12.59 | -6.36 | -2.04 | -1.20 | 0.33 |
CCM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.46x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.68x to 0.46x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.46 | 0.46 | 0.32 | 0.68 | 0.73 | 1.32 | 0.45 | 1.41 | 1.00 | 1.26 | 0.99 |
| Quick Ratio | 0.45 | 0.45 | 0.30 | 0.60 | 0.68 | 1.28 | 0.44 | 1.41 | 1.00 | 1.25 | 0.99 |
| Cash Ratio | 0.17 | 0.17 | 0.03 | 0.14 | 0.20 | 0.65 | 0.12 | 0.52 | 0.09 | 0.20 | 0.42 |
| Asset Turnover | — | 0.06 | 0.09 | 0.08 | 0.08 | 0.04 | 0.05 | 0.04 | 0.10 | 0.14 | 0.17 |
| Inventory Turnover | 13.85 | 13.85 | 15.22 | 7.36 | 14.25 | 9.71 | 49.34 | 50.99 | 37.07 | 48.38 | 90.67 |
| Days Sales Outstanding | — | 48.64 | 49.92 | 100.72 | 287.89 | 307.96 | 222.92 | 388.32 | 326.78 | 241.48 | 227.08 |
CCM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Concord Medical Services Holdings Limited does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | 100.0% | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Shares Outstanding | — | $145600 | $145600 | $145600 | $145600 | $145600 | $144700 | $144566 | $144533 | $145133 | $149500 |
Peer Comparison
Compare CCM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CCMYou | $748461 | -0.0 | — | — | -20.6% | -138.6% | -18.3% | -7.7% | — |
 RDNT | $4B | -230.0 | 25.9 | 52.0 | — | 3.0% | 3.8% | 2.0% | 8.7 |
 USPH | $897M | 41.5 | 12.5 | 14.7 | 20.1% | 10.3% | 2.0% | 5.6% | 4.1 |
 AMSF | $569M | 12.3 | 8.5 | 63.8 | 46.4% | 18.6% | 18.5% | 21.9% | 0.0 |
 ARAY | $35M | -18.9 | 11.0 | — | 32.1% | 1.7% | -2.5% | 3.0% | 12.6 |
 MLAB | $586M | -294.8 | 18.1 | 13.9 | 62.6% | 6.8% | -1.3% | 3.7% | 4.4 |
 ISRG | $161B | 57.6 | 43.6 | 64.7 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 EW | $48B | 45.2 | 25.4 | 35.7 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 HCA | $96B | 15.1 | 9.4 | 12.5 | 41.5% | 15.8% | — | 19.9% | 3.2 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 17 years · Updated daily
See CCM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCM vs RDNT
Side-by-side business, growth, and profitability comparison vs RadNet, Inc..
Start ComparisonCCM — Frequently Asked Questions
Quick answers to the most common questions about buying CCM stock.
What is Concord Medical Services Holdings Limited's P/E ratio?
Concord Medical Services Holdings Limited's current P/E ratio is -0.0x. The historical average is 0.9x.
What is Concord Medical Services Holdings Limited's ROE?
Concord Medical Services Holdings Limited's return on equity (ROE) is -18.3%. The historical average is -7.3%.
Is CCM stock overvalued?
Based on historical data, Concord Medical Services Holdings Limited is trading at a P/E of -0.0x. Compare with industry peers and growth rates for a complete picture.
What are Concord Medical Services Holdings Limited's profit margins?
Concord Medical Services Holdings Limited has -20.6% gross margin and -138.6% operating margin.